Research Topics
| Katia NoyesSummaryAffiliation: University of Rochester Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
What is the risk of developing parkinsonism following neuroleptic use?Katia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine, Rochester, NY, USA
Neurology 66:941-3. 2006..Although more research is needed, these data suggest that 126 Medicare beneficiaries would need to be treated with neuroleptic medications to cause one additional case of self-reported PD...
Cost-effectiveness of the School-Based Asthma Therapy (SBAT) programKatia Noyes
Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA
Pediatrics 131:e709-17. 2013..The objective of this study was to examine cost-effectiveness (CE) of the School-Based Asthma Therapy (SBAT) program compared with usual care (UC)...
Cost-effectiveness of cardiac resynchronization therapy in the MADIT-CRT trialKatia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14620, USA
J Cardiovasc Electrophysiol 24:66-74. 2013....- Medicare beneficiaries with depression: comparing diagnoses in claims data with the results of screeningKatia Noyes
Department of Community and PreventiveMedicine, University ofRochester School of Medicine, Rochester, NY, USA
Psychiatr Serv 62:1159-66. 2011..The study evaluated the accuracy of Medicare claims in identifying elderly patients with depression compared with diagnoses of depression made with validated self-report depression scales... - Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based studyK Noyes
Department of Community and Preventive Medicine, University of Rochester, 601 Elmwood Ave, Box 644, Rochester, NY 14620, USA
Neurology 77:355-63. 2011..To evaluate the cost-effectiveness of disease-modifying therapies (DMTs) in the United States compared to basic supportive therapy without DMT for patients with relapsing multiple sclerosis (MS)... - Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-IIKatia Noyes
Departments of Community and Preventive Medicine, University of Rochester Medical Center, Rochester, New York, USA
Am J Cardiovasc Drugs 9:393-400. 2009..A higher prevalence of CHF and shocks among patients with ICDs and their negative effect on HRQOL may partially explain the lack of HRQOL benefit of ICD therapy... - Medicare capitation model, functional status, and multiple comorbidities: model accuracyKatia Noyes
Department of Community and Preventive Medicine, University of Rochester, Rochester, NY 14620, USA
Am J Manag Care 14:679-90. 2008..To examine financial implications of the Centers for Medicare & Medicaid Services Hierarchical Condition Categories (CMS-HCC) risk-adjustment model on Medicare payments for individuals with comorbid chronic conditions... - The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluationKatia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine, Rochester, New York 14620, USA
Med Decis Making 27:327-34. 2007..The objective of this study is to examine the effect of country-specific EQ-5D preference weights on the cost-effectiveness (CE) of initial pramipexole versus levodopa strategy in patients with Parkinson disease (PD)... - Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT IIKatia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14620, USA
Med Care 45:377-85. 2007..Implantable cardioverter defibrillators (ICDs) improve survival and extend lives of patients with severe heart disease... - Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary surveyKatia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine, Rochester, New York, USA
Mov Disord 22:509-14. 2007..This study evaluates the accuracy of administrative claims in identifying Parkinsonism cases compared to the self-reported Parkinson's disease (PD)... - Economic burden associated with Parkinson's disease on elderly Medicare beneficiariesKatia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine, Rochester, New York, NY 14620, USA
Mov Disord 21:362-72. 2006..Although more research is needed to understand the relationship between PD and medical expenditures and utilization, these findings have important implications for health care providers and payers that serve PD populations... - Cost of caring for Medicare beneficiaries with Parkinson's disease: impact of the CMS-HCC risk-adjustment modelKatia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine, Rochester, New York 14620, USA
Dis Manag 9:339-48. 2006..If the CMS-HCC payment model were to apply to programs that draw a significant percentage of their participants from the Parkinson's disease community, these programs likely would be compensated fairly... - Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectivenessKatia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine, Rochester, New York 14620, USA
Pharmacoeconomics 23:1257-70. 2005..In this article we analyse the dynamic changes in cumulative costs, effects and incremental cost effectiveness of two competing drug strategies in patients with early Parkinson's disease (PD)... - Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of lifeKatia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine, Rochester, NY 14620, USA
Value Health 9:28-38. 2006..Here we assess the effect of therapy on HRQOL and explore factors that influence the HRQOL profiles and subdomains... - A cost-utility comparison of four first-line medications in painful diabetic neuropathyAlec B O'Connor
Department of Medicine, University of Rochester School of Medicine and Dentistry, University of Rochester, Rochester, New York 14642, USA
Pharmacoeconomics 26:1045-64. 2008..Painful diabetic neuropathy is common and adversely affects patients' quality of life and function. Several treatment options exist, but their relative efficacy and value are unknown... - Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trialKatia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine, Rochester, New York, USA
Med Decis Making 24:472-85. 2004..If initial pramipexole results in long-term improvements in quality of life, its cost-effectiveness will become more favorable... - Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudyDavid T Huang
Cardiology Unit, The Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
J Cardiovasc Electrophysiol 18:833-8. 2007..Effective primary prevention of sudden cardiac death with implantable cardioverter defibrillators is well demonstrated in patients with coronary disease and depressed ventricular function... - Cost-effectiveness of testing for breast cancer susceptibility genesMargaret L Holland
Department of Community and Preventive Medicine, University of Rochester, Rochester, NY 14620, USA
Value Health 12:207-16. 2009..Cost-effective preventive measures are available for women who test positive. The objective of this study was to determine at what risk of mutation it is cost-effective to test women for BRCA1/2 mutations... - Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overviewEmil Scosyrev
Department of Community and Preventive Medicine, University of Rochester, Rochester, NY 14642, USA
Urol Oncol 30:126-32. 2012.... - Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failurePeter J Veazie
Department of Community and Preventive Medicine, University of Rochester Medical Center, Rochester, New York Electronic address
J Am Coll Cardiol 60:1940-4. 2012..This study compared the quality of life (QOL) of patients with cardiac resynchronization therapy (CRT) and an implantable cardioverter-defibrillator (ICD) to patients with an ICD only... - Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial IIKatarzyna Piotrowicz
Heart Research Follow Up Program, Cardiology Division, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Ave, PO Box 653, Rochester, NY 14642, USA
Eur Heart J 28:601-7. 2007..The aim of this study was to assess the physical and mental health in relationship to health outcome in post-infarction patients with advanced left ventricular dysfunction... - Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison studyChad Heatwole
Department of Neurology, University of Rochester, Rochester, NY 14642, USA
J Clin Neuromuscul Dis 13:85-94. 2011..To compare the short-term financial costs of treating a patient in myasthenia gravis crisis with intravenous immunoglobulin (IVIG) versus plasma exchange... - The economic impact of S-100B as a pre-head CT screening test on emergency department management of adult patients with mild traumatic brain injuryShuolun Ruan
Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
J Neurotrauma 26:1655-64. 2009..Despite its high sensitivity and excellent negative predictive value, serum S-100B has low specificity and low positive predictive value, limiting its ability to reduce numbers of CT scans and hospital costs... - Evidence from cost-effectiveness researchKatia Noyes
Department of Community and Preventive Medicine, University of Rochester, NY 14620, USA
NeuroRx 1:348-55. 2004.... - Acute illness care patterns change with use of telemedicineKenneth M McConnochie
Department of Pediatrics, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, USA
Pediatrics 123:e989-95. 2009.... - Teaching and evaluating first and second year medical students' practice of evidence-based medicineRobert Holloway
Department of Neurology, University of Rochester, 1351 Mount Hope Avenue, Suite 220, Rochester, NY 14620, USA
Med Educ 38:868-78. 2004..To implement an evidence-based medicine (EBM) curriculum for Year 1 and 2 medical students, and to develop a method to evaluate their practice of EBM in discrete and relevant worksteps... - Self-reported cancer screening among elderly Medicare beneficiaries: a rural-urban comparisonLin Fan
Department of Community and Preventive Medicine, University of Rochester, Rochester, New York, USA
J Rural Health 28:312-9. 2012..We examined the rural-urban disparity of screening for breast cancer and colorectal cancer (CRC) among the elder Medicare beneficiaries and assessed rurality's independent impact on receipt of screening... - Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumorsRalph Madeb
Department of Urology, University of Rochester School of Medicine, Rochester, New York, USA
Cancer 115:2660-70. 2009..The authors sought to determine whether US urologists have adopted this practice, and its potential effect on costs of bladder cancer (BC) care... - Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factorsKatia Noyes
Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
Curr Opin Urol 18:533-9. 2008..This study describes the principals of cost-effectiveness evaluation in healthcare and provides recommendations for a more economical use of resources in bladder cancer care... - A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgiaAlec B O'Connor
Department of Medicine, School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA
J Am Geriatr Soc 55:1176-84. 2007..To compare the net health effects and costs resulting from treatment with different first-line postherpetic neuralgia (PHN) medications... - Quality outcomes of hospital supplemental nurse staffingYing Xue
School of Nursing, University of Rochester, New York
J Nurs Adm 42:580-5. 2012..4% in ICUs. All observed effects of SRN use on patient outcomes were nonsignificant. Use of SRNs was substantial and varied widely by unit. No evidence was found that links SRN use to either adverse or positive patient outcomes... - Sex and racial differences in bladder cancer presentation and mortality in the USEmil Scosyrev
Department of Community and Preventive Medicine, University of Rochester, Rochester, New York 14642, USA
Cancer 115:68-74. 2009....
Research Grants
- Economic and Policy Analyses in Geriatric DiseaseEKATERINA NOYES; Fiscal Year: 2006..The model and analytical approaches acquired by the candidate during her training will be used later to develop a decision analytical model describing geriatric depression. ..